| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0099 | 1 |